"Attention of the Holders of Securities in Physical Mode is invited to Circular No. SEBI/HO/MIRSD/PoD-1/P/CIR/2023/181 dated November 17, 2023 issued by SEBI."
Home
About Us
Company Profile
Corporate ETHOS
Mission
Vision
Board of Directors and KMPs
Board Committees
Products
Speciality Chemicals
Skin Care Products
Hospital Care Products
Generics
Investors
Financial Information
Investor Information
Annual Reports
Shareholding Pattern
Corporate Governance
Policies
Other Data
Newsapaper Publication
Shareholders Meetings/Other Disclosures
Disclosure under Reg 46 of SEBI (LODR) Regulations 2015.
Media
News & Press Release
Contact Us
Q3
Outcome Of The 1St Extraordinary General Meeting For The Financial Year 2022-23
Closure of Trading Window
Intimation Of Shareholders Meeting - EGM To Be Held On December 31, 2022 At 12.00 Noon
Board Meeting Outcome for Outcome Of The Board Meeting Held On 06.12.2022
Board Meeting Intimation for Calling Of 1St Extraordinary General Meeting For The Financial Year 2022-23 & Other Matters
Board Meeting Outcome for Revised Outcome
Board Meeting Outcome for Board Meeting Outcome For Preferential Issue And Other Related Matter
Regulation 23(9)- Disclosure of Related Party Transaction for the half year ended September, 2022
Closure of Trading Window
Board Meeting Intimation for Appointment Of Independent Director And Preferential Issue Of Equity Shares And Other Business Matters
Unaudited Financial Results For The Quarter And Half-Year Ended September 30, 2022
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''SEBI LODR'')
Unaudited Financial Results Along With The Limited Review Report For The Quarter And Half-Year Ended September 30, 2022
Board Meeting Intimation for Considering The Unaudited Financial Results For The Quarter And Half-Year Ended September 30, 2022.
Announcement under Regulation 30 (LODR)-Change in Directorate
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Appointment of Company Secretary and Compliance Officer
Board Meeting Outcome for Allotment Of Equity Share Warrants On Preferential Basis
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Board Meeting Intimation for Allotment Of Equity Share Warrants On Preferential Basis
Home
About Us
Company Profile
Corporate ETHOS
Mission
Vision
Products
Personal Care Ingredients
Generics Ingredients
Hospital Care Products
Sking Care Products
Investors
Financial Information
Board of Directors
Annual Reports
Listing Updates
Shareholding Pattern
Corporate Governance
Half Yearly Compliances
Media
News & Press Release
Corporate Announcement
Gallery
Contact Us